2022 Atlanta Board of Trustees Meeting

14. Six New Obesity Drugs Set to Launch by 2026. Global Data . Published online November 18, 2018. Accessed October 26, 2021. https://www.globaldata.com/six-new-obesity-drugs-set-launch- 2026/ 15. Casanova D, Kushner RF, Ciemins EL, et al. Building Successful Models in Primary Care to Improve the Management of Adult Patients with Obesity. Population Health Management . 2021;24(5). doi:10.1089/pop.2020.0340 16. Foster D, Sanchez-Collins S, Cheskin LJ. Multidisciplinary Team–Based Obesity Treatment in Patients With Diabetes: Current Practices and the State of the Science. Diabetes Spectrum . 2017;30(4). doi:10.2337/ds17-0045 17. Silberman JM, Kaur M, Sletteland J, Venkatesan A. Outcomes in a digital weight management intervention with one-on-one health coaching. PLOS ONE . 2020;15(4). doi:10.1371/journal.pone.0232221 18. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 . Diabetes Care . 2018;41(Supplement 1). doi:10.2337/dc18-S002 19. Garber AJ, Handelsman Y, Grunberger G, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary. Endocrine Practice . 2020;26(1). doi:10.4158/CS-2019-0472 20. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice . 2016;22(7). doi:10.4158/EP161356.ESGL 18. Kaplan LM, Golden A, Jinnett K, et al. Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study. Obesity . 2018;26(1). doi:10.1002/oby.22054 19. Kraschnewski J, Yeh H, Francis E, et al. Utilization of intensive behavioural treatment for obesity in patients with diabetes. Clinical Obesity . 2021;11(1). doi:10.1111/cob.12426 20. Thomas CE, Mauer EA, Shukla AP, Rathi S, Aronne LJ. Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s. Obesity . 2016;24(9). doi:10.1002/oby.21533 21. Ozoor M, Gritz M, Dolor RJ, Holtrop JS, Zhehui L. Primary Care Provider Uptake of Intensive Behavioral Therapy for Obesity in Medicare Patients, 2012-2017. PREPRINT (Version 1) available at Research Square . 22. United States Government Accountability Office. Obesity Drugs-Few Adults Used Prescription Drugs for Weight Loss and Insurance Coverage Varied .; 2019. Accessed November 15, 2021. https://www.gao.gov/assets/gao-19-577.pdf 23. Phelan SM, Burgess DJ, Yeazel MW, Hellerstedt WL, Griffin JM, Ryn M. Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. Obesity Reviews . 2015;16(4). doi:10.1111/obr.12266

8